United Therapeutics (UTHR) announced Wednesday that the FDA has accepted its marketing application that seeks a U.S. label expansion for a nebulized version of its lead product, Tyvaso, for idiopathic ...
United Therapeutics UTHR recently announced that the FDA has accepted its supplemental new drug application (sNDA) for review ...
The last time I spoke about United Therapeutics (UTHR) it was with respect to a Seeking Alpha article entitled "United Therapeutics: Ability To Expand Tyvaso To Large IPF Market". With respect to this ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the supplemental New Drug Application ( sNDA) for nebulized Tyvaso ® ...
United Therapeutics Corporation ( UTHR ), announced that the U.S. FDA has accepted its supplemental New Drug Application for nebulized Tyvaso Inhalation Solution to treat Idiopathic pulmonary fibrosis ...
Shares of United Therapeutics UTHR surged 33% on Tuesday after it announced positive top-line results from the late-stage TETON-2 study evaluating the nebulized version of Tyvaso (treprostinil) in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the first patient has enrolled ...
United Therapeutics Corporation (NASDAQ:UTHR) released data on Tuesday from its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for idiopathic pulmonary ...
(RTTNews) - United Therapeutics Corp. (UTHR), Tuesday announced that its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for the treatment of idiopathic ...
Operator: Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2026 Corporate Update. My name is JL, and I'll be your conference operator today. [Operator Instructions] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results